PREVEST DENPRO Financial Statement Analysis
|
||
|
The Revenues of PREVEST DENPRO have decreased by 0.00% YoY .
The Earnings Per Share (EPS) of PREVEST DENPRO has increased by 12.57 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
PREVEST DENPRO Last 5 Annual Financial Results
[BOM: 543363]
| Consolidated | Mar2025 | Mar2024 |
|---|---|---|
| Revenues | ₹56 Cr | ₹56 Cr |
| Expenses | ₹36 Cr | ₹36 Cr |
| Operating Profit (Excl OI) | ₹20 Cr | ₹20 Cr |
| Other Income | ₹2.86 Cr | ₹2.86 Cr |
| Interest | ₹0.21 Cr | ₹0.21 Cr |
| Depreciation | ₹1.28 Cr | ₹1.28 Cr |
| Profit Before Tax | ₹21 Cr | ₹21 Cr |
| Profit After Tax | ₹16 Cr | ₹16 Cr |
| Consolidated Net Profit | ₹16 Cr | ₹16 Cr |
| Earnings Per Share (Rs) | ₹15.13 | ₹13.44 |
| PAT Margin (%) | 27.95 | 27.59 |
| ROE(%) | 18.70 | 18.21 |
| ROCE(%) | 25.24 | 24.42 |
| Total Debt/Equity(x) | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 622.8 Cr |
| Revenue (TTM) | : | ₹ 65.4 Cr |
| Net Profit(TTM) | : | ₹ 18.9 Cr |
| EPS (TTM) | : | ₹ 15.7 |
| P/E (TTM) | : | 33.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PREVEST DENPRO | -4.6% | -11% | -10.6% |
| POLY MEDICURE | 2.2% | -4.6% | -22.8% |
| NURECA | 24.5% | 14.2% | -23% |
PREVEST DENPRO Revenues
[BOM: 543363]
| Y-o-Y | 0.00 % |
| 5 Yr CAGR | 0.00 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹56 Cr | 0.00 | |
| Mar2024 | ₹56 Cr | - | |
PREVEST DENPRO Operating Profit
[BOM: 543363]
| Y-o-Y | 0.00 % |
| 5 Yr CAGR | 0.00 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹20 Cr | 0.00 | |
| Mar2024 | ₹20 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 0.00 % |
| 5 Yr CAGR | 0.00 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 35.55% | 0.00 | |
| Mar2024 | 35.55% | - | |
PREVEST DENPRO Profit After Tax
[BOM: 543363]
| Y-o-Y | 0.00 % |
| 5 Yr CAGR | 0.00 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | 0.00 | |
| Mar2024 | ₹16 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 1.30 % |
| 5 Yr CAGR | 1.30 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 27.95 % | 1.30 | |
| Mar2024 | 27.59 % | - | |
PREVEST DENPRO Earnings Per Share (EPS)
[BOM: 543363]
| Y-o-Y | 12.57 % |
| 5 Yr CAGR | 12.57 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹15 | 12.57 | |
| Mar2024 | ₹13 | - | |
PREVEST DENPRO Return on Capital Employed (ROCE)
[BOM: 543363]
| Y-o-Y | 3.36 % |
| 5 Yr CAGR | 3.36 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 25.24% | 3.36 | |
| Mar2024 | 24.42% | - | |
PREVEST DENPRO Share Price vs Sensex
| Current Share Price | : | ₹519.0 |
| Current MarketCap | : | ₹ 622.8 Cr |
| Updated EOD on | : | Oct 17,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PREVEST DENPRO | -4.6% |
-11% |
-10.6% |
| SENSEX | 1.8% |
1.9% |
2.4% |
PREVEST DENPRO related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about PREVEST DENPRO Financials
How the annual revenues of PREVEST DENPRO have changed ?
The Revenues of PREVEST DENPRO have decreased by 0.00% YoY .
How the Earnings per Share (EPS) of PREVEST DENPRO have changed?
The Earnings Per Share (EPS) of PREVEST DENPRO has increased by 12.57 % YoY .
Check out Intrinsic Value of Peers of PREVEST DENPRO
|
Intrinsic Value of POLY MEDICURE LTD Intrinsic Value of NURECA LTD |
